Aspen Aerogels Hits 52-Week Low of $3.70 Amidst Major Decline

Aspen Aerogels, Inc., a microcap player in the Other Industrial Products sector, has reached a new 52-week low of USD 3.70 on November 7, 2025. This significant decline reflects a challenging year for the company, which has seen its stock price plummet by 87.69% over the past year, starkly contrasting with the S&P 500's performance of 12.65% during the same period.
The company's financial metrics indicate a difficult operating environment, with a return on equity (ROE) of just 6.05%, suggesting limited profitability relative to shareholder funds. Additionally, Aspen Aerogels has reported a substantial decline in operating profit, down 58.5%, and has faced six consecutive quarters of negative results. The latest quarterly figures show a pre-tax profit of USD -2.34 million and a net profit of USD -3.16 million, marking significant year-over-year declines.

With a market capitalization of USD 557 million, Aspen Aerogels is navigating a challenging landscape, characterized by a price-to-book ratio of 1.80 and a debt-equity ratio of -0.09. The stock's performance has raised concerns about its management efficiency and overall market position.